Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), attended a virtual press briefing at the headquarters in Geneva, Switzerland, on the 7th (local time). During the briefing, he stated, "WHO has added the Sinopharm Beijing COVID-19 vaccine to the Emergency Use Listing," adding, "It is the sixth vaccine to be confirmed by WHO for safety, efficacy, and quality." <Photo by Xinhua>

Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), attended a virtual press briefing at the headquarters in Geneva, Switzerland, on the 7th (local time). During the briefing, he stated, "WHO has added the Sinopharm Beijing COVID-19 vaccine to the Emergency Use Listing," adding, "It is the sixth vaccine to be confirmed by WHO for safety, efficacy, and quality."

View original image


The World Health Organization (WHO) recently approved the emergency use of the COVID-19 vaccine developed by the Chinese pharmaceutical company Sinopharm, and China welcomed this, stating that the vaccine's safety and efficacy have been recognized.


Hua Chunying, spokesperson for the Chinese Ministry of Foreign Affairs, said at a regular briefing on the 10th, "The Chinese vaccine is a safe, effective, and high-quality vaccine recognized by the WHO," adding, "We will contribute to ensuring that developing countries can receive vaccines equitably to overcome infectious diseases globally."


She also pledged to fulfill the promise of providing 10 million doses (single-dose units) of the vaccine to the international project for joint vaccine procurement and distribution, the COVAX facility.


Spokesperson Hua Chunying further emphasized, "China is supplying vaccines to more than 80 developing countries and exporting vaccines to over 50 countries," adding, "We will be the country supplying the most vaccines to developing countries."



Earlier, on the 7th (local time), the WHO approved the emergency use of the COVID-19 vaccine developed by the Chinese pharmaceutical company Sinopharm. This is the first COVID-19 vaccine developed in a non-Western country to receive WHO emergency use approval.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing